Company Info
My Analysis
Accounting Ratio
My notes based on 2012 quarter 1 report (number in '000):-
- Revenue and profit before taxation for the period was mainly derived from contribution from our newly acquired incubatee, Ecompazz IT Sdn Bhd ("eCompazz") in the form of IT services fees and sales of our agro/biotechnology division with our new venture into paddy plantation in Cambodia using our microbial biotechnology planting methodology
- Estimate next 4Q eps after 2012 Q1 result announced = 0.0004*4*1.05 = 0.0017, estimate PE on current price 0.055 = 32.35
- Estimate next 4Q eps after 2011 Q4 result announced = (0.001+0.0023)/2 = 0.0017, estimate highest/lowest PE = 47.06/32.35
- Estimate next 4Q eps after 2011 Q3 result announced = 0.0042, estimate highest/lowest PE = 20.24/13.1
- Estimate next 4Q eps after 2011 Q2 result announced = 0.0042, estimate highest/lowest PE = 19.05/14.29
- Estimate next 4Q eps after 2011 Q1 result announced = 0.0036+0.0006(average of eps per quarter in year 2009)*4 = 0.006, estimate highest/lowest PE = 14.17/10.08
ASIABIO latest news (English)
ASIABIO latest news (Chinese)
Market Capital (Capital Size) | 19,635,000 (Very Small) |
Par Value | RM 0.10 |
My Analysis
Forecast P/E now | 0.055/0.0017 = 32.35 (High) |
Target Price | 0.0017*4.0 = 0.01 (PE 4.0, EPS 0.0017) |
Decision | Not interested unless revenue and profit stabilize more |
Comment | Revenue decreased 7.3% and also lower than preceding year corresponding quarter 77.8%, eps decreased 166.7% and is third consecutive quarter decreasing and also lower than preceding year corresponding quarter 260%, no cash generated from operating and cash generated from financing activity also finish spent on investing activities, weakeaning liquidity but still at high level now, higher gearing ratio but still at low level now, receivables turnover period getting longer but working capital no increase, IT division back to contribution again |
First Support Price | 0.06 |
Second Support Price | 0.055 |
Risk Rating | HIGH |
Accounting Ratio
Return on Equity | -1.85% |
Dividend Yield | - |
Profit Margin | 36.94% |
Tax Rate | - |
Asset Turnover | 0.0598 |
Net Asset Value Per Share | 0.12 |
Net Tangible Asset per share | 0.08 |
Price/Net Tangible Asset Per Share | 0.69 |
Cash Per Share | 0.0 |
Liquidity Current Ratio | 3.991 |
Liquidity Quick Ratio | 3.3253 |
Liquidity Cash Ratio | 0.8579 |
Gearing Debt to Equity Ratio | 0.1042 |
Gearing Debt to Asset Ratio | 0.0856 |
Working capital per thousand Ringgit sale | 174.6% |
Days to sell the inventory | 184 |
Days to collect the receivables | 499 |
Days to pay the payables | 241 |
My notes based on 2012 quarter 1 report (number in '000):-
- Revenue and profit before taxation for the period was mainly derived from contribution from our newly acquired incubatee, Ecompazz IT Sdn Bhd ("eCompazz") in the form of IT services fees and sales of our agro/biotechnology division with our new venture into paddy plantation in Cambodia using our microbial biotechnology planting methodology
- Estimate next 4Q eps after 2012 Q1 result announced = 0.0004*4*1.05 = 0.0017, estimate PE on current price 0.055 = 32.35
- Estimate next 4Q eps after 2011 Q4 result announced = (0.001+0.0023)/2 = 0.0017, estimate highest/lowest PE = 47.06/32.35
- Estimate next 4Q eps after 2011 Q3 result announced = 0.0042, estimate highest/lowest PE = 20.24/13.1
- Estimate next 4Q eps after 2011 Q2 result announced = 0.0042, estimate highest/lowest PE = 19.05/14.29
- Estimate next 4Q eps after 2011 Q1 result announced = 0.0036+0.0006(average of eps per quarter in year 2009)*4 = 0.006, estimate highest/lowest PE = 14.17/10.08
ASIABIO latest news (English)
ASIABIO latest news (Chinese)
No comments:
Post a Comment